To the question of improving the outcomes of surgical treatment of genital prolapse in postmenopausal women

Currently, the frequency of genital prolapse in the structure of common gynecological diseases has no tendency to decrease and may take up to 15% of large gynecological operations. With the aim of improving outcomes of surgical treatment of this category of patients, at the stage of preoperative preparation and the postoperative period used vaginal capsules containing Lactobacillus + progesterone 2 mg + estriol 0.2 mg (Triozhinal). The study included 239 patients in postmenopausal women with genital prolapse and phenomena cystourethroscopy and vaginal atrophy. Of these, the main group consisted of 122 women who underwent the proposed scheme of preoperative preparation and postoperative period. Group comparisons were presented 117 patients admitted to the gynecological Department for surgical treatment of prolapse with traditional preoperative and postoperative management. The results of the study showed that in the group of patients receiving local therapy estriola in combination with progesterone and lactobacilli, was observed a significant improvement of the clinical picture of urinary disorders, quality of life, symptoms of urogenital atrophy during surgical correction of urinary incontinence or genital prolapse, and this tactic can be recommended as in the pre-and postoperative periods.

вагинальная атрофия, эстроген-дефицит, пролапс гениталий, лечение, vaginal atrophy, estrogen deficit, prolapse genitalium, treatment

1. Monz D., Pons M., Hampel C., Hunskaer S., Quail D., Samsioe G., Sykes D., Wagg A., Papanicolaou S. Patien - repoted impact of urinary incontinence. Results from treatment seeking women in 14 European countries. Maturitas. 2005;52 (2):25-28.

2. Гвоздев М.Ю., Тупикина Н.В., Касян Г.Р., Пушкарь Д.Ю. Пролапс тазовых органов в клинической практике врача-уролога. Методические рекомендации 3. - М., 2016. - 58 с.

3. Garshasbi A., Faghih-Zadeh S., Falah N. The status of pelvic supporting organs in a population of iranian women 18-68 years of age and possible related factors. Arch Iran Med 2006;9(2):124-8.

4. Nygaard I., Barber M. D., Burgio K. L. Prevalence of symptomatic pelvic floor disorders in US women. JAMA 2008; 300 (11):1311-6.

5. Кулаков В. И., Чернуха Е. А., Гус А. И. и др. Оценка состояния тазового дна после родов через естественные родовые пути. Акушерство и гинекология. 2004: 26-30.

6. Hendrix S. L., Clark A., Nygaard I. et al. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol 2002;186 (6):1160-6.

7. Wu J. M., Matthews C. A., Conover M. M. et al. Lifetime risk of stress urinar incontinence or pelvic organ prolapse surgery. Obstet Gynecol 2014;123 (6):1201-6.

8. Management of symptomatic vulvovaginal atrophy: 2013 position statement of The North American Menopause Society. The North American Menopause Society. 2013; 20 (9): 888-902.

9. James H.Pickar. Emerging therapiesfor postmenopausal vaginal atrophy. Maturitas. 2013; 75: 3-6.

10. Camil Castelo-Branco, Maria Jes'us Cancelo, Jose Villero, Francisco Nohales, Maria Dolores Juli'a. Management of post-menopausal vaginal atrophy and atrophic vaginitis. Maturitas. 2005; 52: 46-52.

11. Santiago Palacios. Managing urogenital atrophy. Maturitas. 2009; 63: 315-318.

12. Лихачев А.В., Галянская Е.Г., Шевлягина Л.С., Полянская И.Б. Терапия эстрогендефицитных состояний в климактерическом периоде. Акушерство, гинекология и репродукция. 2008; 1: 4-6.

13. Cody J. D., Richardson K., Moehrer B., Hextall A., GlazenerC. M. Oestrogen therapy for urinary incontinencein post-menopausal women. Cochrane Database SystRev. 2009, Oct 7; (4): CD001405.

14. Fitzgerald M. P., Brubaker L. Urinary incontinence symptom score sanduro dynamicdiagnoses. Neurourol Urodin 2002; 21: 30-35.

15. Jackson S., James M., Abrams P. The effect of oestradiol jnvaginal collagen metabolismin.postmenopausal women with genuine stress incontinence. BJOG. 2002; 109:339-344

16. Балан В. Е. Урогенитальные расстройства в климактерии (клиника, диагностика, заместительная гормонотерапия). Дис.. докт. мед. наук. М., 1988.

17. Chollet JA, Carter G, Meyn LA, Mermelstein F, Balk JL. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis. Menopause. 2009 Sep-Oct;16 (5):978-83.

18. Rahn DD, Good MM, Roshanravan SM, Shi H, Schaffer JI, Singh RJ, Word RA. Effects of preoperative local estrogen in postmenopausal women with prolapse: a randomized trial. J Clin Endocrinol Metab. 2014 Oct;99 (10):3728-36.